NCT05646732

Brief Summary

In post-traumatic stress disorder (PTSD), intrusive, traumatic, autobiographical memories lead to anxiety symptoms. Recent work suggests a new repetitive pulse transcranial magnetic stimulation (rTMS) brain target that might bring relief. Since this proposed target is not well understood, the goal of the study is to use functional magnetic resonance imaging (fMRI) to identify the brain regions and networks that change with rTMS stimulation at this target area in PTSD patients. Ultimately, this would lead to a personalized approach to rTMS treatment of PTSD based on brain imaging that can be used in a future clinical trial. Participants will be asked to complete psychological testing and questionnaires as well as an initial MRI and two separate TMS-fMRI sessions. Total participation time across all visits is estimated to be five to six hours. Research participation will take place at VA Palo Alto as well as at Stanford University.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 2, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

August 2, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

April 3, 2024

Status Verified

April 1, 2024

Enrollment Period

1.5 years

First QC Date

December 2, 2022

Last Update Submit

April 1, 2024

Conditions

Keywords

Transcranial Magnetic StimulationTMSMagnetic Resonance ImagingMRIfMRITMS-fMRI

Outcome Measures

Primary Outcomes (3)

  • Resting-State fMRI Connectivity

    Measure of the connectivity between the left 8Av and DMN nodes.

    During the resting state fMRI (rsfMRI) session

  • FMRI BOLD Response

    Measure of the immediate activation (blood-oxygen-level-dependent change) in the brain regions related to PTSD following transcranial magnetic stimulation using interleaved TMS and fMRI.

    During the TMS-fMRI session

  • Changes in Connectivity after cTBS

    Measure of the connectivity changes between the left 8Av and DMN nodes from the initial resting state fMRI and a resting state fMRI collected immediately following inhibitory TMS (cTBS).

    During the TMS-fMRI session

Study Arms (1)

TMS-fMRI

EXPERIMENTAL

Participants will undergo simultaneous TMS-fMRI as part of this study. There will be two locations stimulated: one control region and one target region. Participants will be randomized with respect to the order of receiving stimulation at the locations, but all participants will receive stimulation at both locations as part of the study. All participants will be considered as one group but order effects will be evaluated as an explanatory variable.

Device: TMS-fMRI

Interventions

TMS-fMRIDEVICE

Participants will undergo simultaneous TMS and fMRI

Also known as: Simultaneous TMS and fMRI, Transcranial Magnetic Stimulation and Functional Magnetic Resonance Imaging
TMS-fMRI

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Between 18 and 55 years of age
  • Ability to maintain a Motor Threshold (MT) with single pulse TMS
  • Ability to safely and comfortably undergo an MRI and TMS
  • Able to read, verbalize, understand, and voluntarily sign the Informed Consent Form prior to participating in any study-specific procedures or assessments.
  • PTSD diagnosis according to the DSM 5, as determined by the Clinician administered PTSD scale (CAPS-5) criteria.
  • Commitment to maintaining a stable medication regimen between the two fMRI sessions

You may not qualify if:

  • Inability to safely and comfortably undergo an MRI. MRI safety will be determined by the center where MRI's are collected.
  • Significant dementia as determined by the Montreal Cognitive Assessments (MoCA)
  • Being in urgent need of care that would make participation impossible
  • Currently taking medications that increase the risk of seizure or influence hemodynamic response
  • Presence of any other condition that has the potential to prevent study completion and/or have a confounding effect on the interpretation of results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto

Palo Alto, California, 94304, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Magnetic Resonance ImagingTranscranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisMagnetic Field TherapyTherapeutics

Study Officials

  • Allyson C Rosen, Ph.D.

    PAVIR/Palo Alto VAHCS/Stanford University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

James Lavacot, BA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
order of presentation is randomized
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: A mechanistic study using TMS-functional MRI
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Neuropsychologist

Study Record Dates

First Submitted

December 2, 2022

First Posted

December 12, 2022

Study Start

August 2, 2023

Primary Completion

January 31, 2025

Study Completion

January 31, 2025

Last Updated

April 3, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Researchers will not share the IPD without VA permission. The research team has requested guidance and if allowed, IPD may be shared, but for now there is no plan to share IPD. This statement will be updated if this changes.

Locations